Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

41 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Serum total testosterone is lower in men with Alzheimer's disease.
Hogervorst E, Williams J, Budge M, Barnetson L, Combrinck M, Smith AD. Hogervorst E, et al. Neuro Endocrinol Lett. 2001 Jun;22(3):163-8. Neuro Endocrinol Lett. 2001. PMID: 11449190
TT was measured in non-fasting serum obtained between 10 and 12 a.m. using a competitive enzyme immunoassay. RESULTS: Men with DAT (n=39) had lower levels (p =0.005) of total serum testosterone (TT=14+/-5 nmol/L) than controls (n=41, TT=18+/-6 nmol/L). ...
TT was measured in non-fasting serum obtained between 10 and 12 a.m. using a competitive enzyme immunoassay. RESULTS: Men with DAT (n …
The soluble transcobalamin receptor (sCD320) in relation to Alzheimer's disease and cognitive scores.
Abuyaman O, Combrinck M, Smith AD, Nexo E. Abuyaman O, et al. Among authors: combrinck m. Scand J Clin Lab Invest. 2017 Sep;77(5):332-337. doi: 10.1080/00365513.2017.1323345. Epub 2017 May 9. Scand J Clin Lab Invest. 2017. PMID: 28486088
Low thyroid-stimulating hormone as an independent risk factor for Alzheimer disease.
van Osch LA, Hogervorst E, Combrinck M, Smith AD. van Osch LA, et al. Neurology. 2004 Jun 8;62(11):1967-71. doi: 10.1212/01.wnl.0000128134.84230.9f. Neurology. 2004. PMID: 15184598
The Hopkins Verbal Learning Test and screening for dementia.
Hogervorst E, Combrinck M, Lapuerta P, Rue J, Swales K, Budge M. Hogervorst E, et al. Dement Geriatr Cogn Disord. 2002;13(1):13-20. doi: 10.1159/000048628. Dement Geriatr Cogn Disord. 2002. PMID: 11731710
Cell cycle kinesis in lymphocytes in the diagnosis of Alzheimer's disease.
Nagy Z, Combrinck M, Budge M, McShane R. Nagy Z, et al. Neurosci Lett. 2002 Jan 11;317(2):81-4. doi: 10.1016/s0304-3940(01)02442-9. Neurosci Lett. 2002. PMID: 11755245
Olfactory impairment is more marked in patients with mild dementia with Lewy bodies than those with mild Alzheimer disease.
Williams SS, Williams J, Combrinck M, Christie S, Smith AD, McShane R. Williams SS, et al. J Neurol Neurosurg Psychiatry. 2009 Jun;80(6):667-70. doi: 10.1136/jnnp.2008.155895. J Neurol Neurosurg Psychiatry. 2009. PMID: 19448090
Levels of CSF prostaglandin E2, cognitive decline, and survival in Alzheimer's disease.
Combrinck M, Williams J, De Berardinis MA, Warden D, Puopolo M, Smith AD, Minghetti L. Combrinck M, et al. J Neurol Neurosurg Psychiatry. 2006 Jan;77(1):85-8. doi: 10.1136/jnnp.2005.063131. Epub 2005 Jun 8. J Neurol Neurosurg Psychiatry. 2006. PMID: 15944180 Free PMC article.
Low free testosterone is an independent risk factor for Alzheimer's disease.
Hogervorst E, Bandelow S, Combrinck M, Smith AD. Hogervorst E, et al. Exp Gerontol. 2004 Nov-Dec;39(11-12):1633-9. doi: 10.1016/j.exger.2004.06.019. Exp Gerontol. 2004. PMID: 15582279
41 results
Jump to page
Feedback